Dr. DeRosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 Park Avenue
Florham Park, NJ 07932Phone+1 973-538-5210Fax+1 973-644-9657
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1983 - 1985
USPHS HospitalInternship, Transitional Year, 1980 - 1981
A. T. Still University Kirksville College of Osteopathic MedicineClass of 1980
Certifications & Licensure
NJ State License 1981 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Study of RP1 Monotherapy and RP1 in Combination With Nivolumab Start of enrollment: 2017 Sep 20
- A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2023 Jan 26
Roles: Principal Investigator
Publications & Presentations
PubMed
- 15 citationsCalmodulin as a Target for New Chemotherapeutic StrategiesWilliam N. Hait, William T. Derosa
Cancer Investigation. 1988-01-01 - 17 citationsHigh-dose cisplatin plus dacarbazine in the treatment of metastatic melanomaJohn R. Murren, William T. Derosa, Henry J. Durivage, Carol A. Davis, Robert W. Makuch
Cancer. 1991-03-15 - 3 citationsThe role of the phorbol ester receptor/protein kinase C in the sensitivity of leukemic cells to anthracyclines.William N. Hait, William T. Derosa
Cancer Communications. 1991-03-01
Press Mentions
Big Data Cancer Platform COTA Secures $3.7M in Funding from InsurerSeptember 23rd, 2014
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
